Targovax ASA (GB:0RIS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circio Holding ASA, a biotech firm specializing in circular RNA therapies, reports a significant reduction in cash burn and advances in its circVec platform and oncology program, TG01. The company has also secured financial stability with a rights issue and commitment from Atlas Capital Markets. Progress includes in vivo proof-of-concept for circVec technology, improved expression rates, and clinical trials for TG01 in collaboration with Janssen and BMS.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
